by The BioPharma Team | Nov 16, 2021 | Bioanalysis, Clinical Research - All Blogs, Phase 1, Scientific Publications, Sponsors
Clinical Research Spotlight: Nicotine Method A Bioanalytical Method for the Analysis of Nicotine in Human Plasma With its boutique bioanalytical laboratory, contract research organization BioPharma Services, Inc. specializes in small molecule bioanalysis with more...
by Rafael Ribeiro | Oct 27, 2021 | Bioanalysis, Scientific Publications
An Effective Approach to Assess Bioequivalence of Fingolimod in Normal Healthy Volunteers Using 0.5 mg Study Dose PRESENTED TO: BioPharma Services Inc.PRESENTED BY: R. Chandani, J. He, F. Trabelsi PURPOSE Fingolimod is indicated for the treatment of patients with...
by Rafael Ribeiro | Oct 27, 2021 | Scientific Publications
Challenge with New FDA Requirement for Partial AUCs for Bioequivalence Assessment of Modified-Release Products PRESENTED TO: BioPharma Services Inc., Toronto, ON, CanadaPRESENTED BY: Juan He, Priscila Pequeno, Yu Ding, Rabiya Chandani, Negar Gharavi, and Fethi...
by Rafael Ribeiro | Oct 27, 2021 | Phase 1, Scientific Publications
Clinical Study Program for 505(b)2 NDA Application – The Fast Path to Approval PRESENTED AT: CSPS Annual Conference, Toronto, Canada (June 2009)PRESENTED BY: Juan He*, Masood Bhatti, and Lorelei Lutter, BioPharma Services Inc. Toronto, ONT, Canada ABSTRACT The...
by Rafael Ribeiro | Oct 22, 2021 | Scientific Publications
The investigation of variability of the pharmacokinetics of mesalamine from mesalamine formulations PRESENTED TO: BioPharma Services Inc.PRESENTED BY: Juan He*, Masood Bhatti, and Lorelei Lutter ABSTRACT Purpose: Mesalamine, which is also called 5-aminosalicylic acid...
by Rafael Ribeiro | Oct 21, 2021 | Phase 1, Scientific Publications
LC/MS/MS without Chromatographic Separation? High Throughput Simultaneous Determination of Valsartan and Hydrochlorothiazide PRESENTED TO: BioPharma Services Inc.PRESENTED BY: A. Tan, K. Awaiye, B. Jose, L. Lutter, F. Trabelsi PURPOSE Although valsartan and...
Recent Comments